Phase I study of oral JM216 given twice daily

• 3 June 1998
• journal article
• clinical trial
• Published by Springer Nature in Cancer Chemotherapy and Pharmacology
• Vol. 42  (2) , 142-148
• https://doi.org/10.1007/s002800050797

Abstract

Keywords

• KEY WORDS PHASE I STUDY
• PHARMACOKINETICS
• JM216
• ORAL ADMINISTRATION
• PLATINUM